Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 March 2020 | Story Xolisa Mnukwa | Photo Supplied
Student Governance dialogue session
The UFS Student Governance office aims to motivate engaged scholarship among students and academia, to act as a reservoir of excellence in governance, and shape an excellent landscape of leadership.

“I’m anticipating philosophical discussions that will unpack moral courage, ethics in leadership, and governance,” said UFS Manager for Student Governance, Buti Mnyakeni, in opening the Division of Student Affairs’ first annual Student Governance Leadership Series (SGL) at the University of the Free State (UFS). 

The Student Governance office intends to encourage engaged scholarship among students and academia to produce a broader landscape of equipped student leaders from the university. 

UFS Vice-Rector: Institutional Change, Student Affairs, and Community Engagement, Prof Puleng LenkaBula, joined by former SRC President, Phiwe Mathe, and student leaders Sam Masingi and Amanda Charles, provided rich and provoking contributions under the theme The concept of good governance. On the first day of the series, the discourse kicked off with problematising the concept, and further led to egocentrism, and Afrocentric modalities of governance. 

The panel also unpacked the exclusivity of governmental systems by discussing institutional and managerial culture, which according to them, results in detached knowledge and ways of thinking. 

Day two of the series focused on discussions around moral courage in the era of ethical decay. Attorney of the High Court and International Economic Law Lecturer at the UFS, Mmiselo Qumba; former Vice-President of the SRC, Bokang Fako; former president of the SRC, Richard Chemaly; and freelance writer, broadcaster, author, and communicator, Ace Moloi, engaged extensively on the influence of personal values on shared ethical standards as a vehicle that can lead to a socially just community and society.

The SGL series established a platform to encourage current and prospective student leaders to reflect, connect, and be innovative in their design thinking as leaders in their respective governance structures.

The Programme Director for the event, Adv Thanduxolo Nkala – an accredited mediator in commercial and court-annexed mediation – reflected on the dialogues as “rich and robust.”

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept